e-learning
resources
European Respiratory Review
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection
Ruben J. Mylvaganam, Joseph I. Bailey, Jacob I. Sznajder, Marc A. Sala
Source:
Eur Respir Rev, 30 (162) 210194; 10.1183/16000617.0194-2021
Journal Issue:
December
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ruben J. Mylvaganam, Joseph I. Bailey, Jacob I. Sznajder, Marc A. Sala. Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection. Eur Respir Rev, 30 (162) 210194; 10.1183/16000617.0194-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Role of influenza virus infection in lung fibrosis
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
Epidemic and pandemic viral infections: impact on tuberculosis and the lung
Source: Eur Respir J, 56 (4) 2001727; 10.1183/13993003.01727-2020
Year: 2020
Association between influenza vaccination and the occurrence of acute exacerbation in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Particularities of pulmonary tuberculosis during the COVID-19 pandemic
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021
Frequency and pathogenicity of rhinovirus associated pulmonary exacerbations in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Malaria and the development of pulmonary fibrosis
Source: Eur Respir J, 50 (6) 1702030; 10.1183/13993003.02030-2017
Year: 2017
Influenza A virus in exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 152s
Year: 2001
Influenza vaccine-induced interstitial lung disease
Source: Eur Respir J 2013; 41: 474-477
Year: 2013
ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment
Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment
Year: 2020
Respiratory viral agents in cystic fibrosis
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005
ERS/ATS joint webinar: Rehabilitation after COVID 19 disease
Source: ERS webinar 2020: ERS/ATS joint webinar: Rehabilitation after COVID 19 disease
Year: 2020
Severe influenza virus H1N1: Lung pathology
Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology
Year: 2010
Update on management of lung infection in cystic fibrosis
Source: Virtual Congress 2020 – Updates in cystic fibrosis
Year: 2020
Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 292s
Year: 2005
ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme
Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme
Year: 2020
The role of hepatitis C virus infections in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 333s
Year: 2005
The challenge of acute exacerbation of pulmonary fibrosis
Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease
Year: 2014
Emergencies in interstitial and immunological lung disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=177
Year: 2006
Modelling pulmonary fibrosis
Source: Annual Congress 2012 - PG4 Experimental models for respiratory medicine: strengths and limitations
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept